Henry Schein, Inc. (NASDAQ:HSIC) Stock Position Lifted by Toronto Dominion Bank

Toronto Dominion Bank boosted its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 6.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 66,997 shares of the company's stock after purchasing an additional 4,218 shares during the quarter. Toronto Dominion Bank owned about 0.05% of Henry Schein worth $4,636,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Olstein Capital Management L.P. lifted its position in Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after purchasing an additional 16,000 shares during the last quarter. Private Management Group Inc. lifted its position in Henry Schein by 5.7% in the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company's stock valued at $24,256,000 after purchasing an additional 18,882 shares during the last quarter. Equitable Trust Co. bought a new stake in Henry Schein in the 4th quarter valued at about $417,000. Savant Capital LLC lifted its position in Henry Schein by 43.9% in the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company's stock valued at $322,000 after purchasing an additional 1,420 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. increased its stake in Henry Schein by 29.9% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 15,854 shares of the company's stock valued at $1,113,000 after buying an additional 3,650 shares during the period. 96.62% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, CEO Bradford C. Connett sold 4,036 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. The trade was a 6.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.08% of the company's stock.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded up $2.42 during midday trading on Tuesday, reaching $74.07. The company's stock had a trading volume of 505,725 shares, compared to its average volume of 1,730,498. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a 50 day moving average price of $67.47 and a 200 day moving average price of $71.56. Henry Schein, Inc. has a one year low of $60.56 and a one year high of $82.49. The company has a market cap of $9.02 billion, a price-to-earnings ratio of 30.48, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the previous year, the firm earned $1.10 EPS. The business's revenue for the quarter was down .1% on a year-over-year basis. On average, equities research analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Ratings Changes

HSIC has been the topic of several research analyst reports. UBS Group lowered their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 26th. Piper Sandler lowered their target price on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a research note on Wednesday, April 30th. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Barrington Research lowered their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. Finally, Wells Fargo & Company lowered their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 6th. Six analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $79.30.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.